PFE Today - Jul 11: Pfizer's Slow Day

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

PFE Today - Jul 11: Pfizer's Slow Day

無料で聴く

ポッドキャストの詳細を見る

Hey, what’s up? It’s Joey here, your friendly neighborhood investor, breaking down the day’s action. Today, we’re talking about Pfizer. It was a bit of a rough ride, closing down just a smidge—like, down 0.33%. Yeah, that one stung a little.

So, what went down? Well, the stock kinda just sat there, barely moving. It wasn’t a huge day for trading, with volume coming in lower than usual. Just 27 million shares changed hands, which is less than half of what we typically see. A slow bleed for sure.

Now, let’s get into the why behind this action. There’s been a lot of chatter about Pfizer lately. Some folks are saying it’s a solid defensive pick in this market. But then, you’ve got Jim Cramer throwing some shade, saying he can’t see where the growth is coming from. Ouch! That’s a tough spot to be in, especially when people are looking for excitement. On the flip side, some articles are highlighting Pfizer’s potential in the AI healthcare space, saying it’s one of three picks worth a closer look. So, it’s like a mixed bag of opinions out there.

And here’s something interesting: there’s chatter about a post-pandemic turnaround happening for Pfizer. They’re seen as undervalued right now, which might mean some upside in the future if they play their cards right. But until then, it’s just a lot of waiting and seeing.

Anyway, that’s the scoop on Pfizer today. If you’re in it for the long haul, hang tight and keep an eye on the news. Remember, I’m just here to keep you informed and entertained, not to give financial advice. Catch you later!

まだレビューはありません